KRT17 and breast carcinoma: The prevalence and poor prognosis of basal-like breast carcinomas have been validated immunohistochemically; in a 564-case tissue microarray, it was demonstrated that 16% of tumors stained positive for cytokeratin5/6 or cytokeratin 17 and that basal cytokeratin expression was associated with a poor prognosis [42].